BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2014
View Archived Issues
Genzyme establishes collaboration to develop gene therapy for Leber's congenital amaurosis
Read More
Baxter and Merrimack sign ex-U.S. license agreement for MM-398
Read More
Celldex Therapeutics begins pilot study of CDX-301
Read More
Alnylam begins study examining the prevalence of TTR mutations in cardiac amyloidosis
Read More
Diaxonhit completes enrollment in validation study of BJI InoPlex
Read More
Repros reports data from second pivotal study of Androxal for secondary hypogonadism
Read More
Additional approval obtained for pediatric administration of Vfend in Japan
Read More
Pfizer completes InnoPharma acquisition
Read More
MicroBiome's NM-505 may improve tolerability of metformin in type 2 diabetes
Read More
Bayer presents data from 11-year follow-up of the BENEFIT trials
Read More
ARN-2508, an orally available therapeutic for the potential treatment of pain and inflammation
Read More
Researchers from Visterra present a novel humanized antibody against dengue virus
Read More
SostAb shows promise for fracture healing in animal models of type 1 diabetes
Read More
Merck & Co. patents novel LRRK2 inhibitors
Read More
Roche divulges new agents for HCV infection
Read More
Novel anticancer agents disclosed by TD2
Read More
EMA committee recommends approval of Rezolsta, announces darunavir label extensions
Read More
New NS5B inhibitors presented by Bristol-Myers Squibb
Read More
Influenza drug Avigan administered to patient with Ebola
Read More
Roche presents new BTK inhibitors
Read More
Lymphoseek recommended by CHMP for sentinel lymph node detection
Read More
Bristol-Myers Squibb provides milestone update for Opdivo
Read More
FDA grants multiple orphan drug designations to aldoxorubicin
Read More
NeuroGenetic cleared to begin phase I trials of NGP-555 for Alzheimer's disease
Read More
FDA awards orphan drug designation to Insys Therapeutics' cannabidiol for glioma
Read More
Daiichi Sankyo and Ambit Biosciences enter merger agreement
Read More
Pegylated liposomal mitomycin-C lipid-based prodrug shows promise in phase I trials
Read More